Status:
COMPLETED
Quality of Life of Very Preterm Children With Dysexecutive Disorders at Elementary School Age During the Confinement-deconfinement Period of Covid-19 Pandemic
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Very Preterm Children With Dysexecutive Disorders
Eligibility:
All Genders
7-9 years
Brief Summary
Since March 2020, a new HCoV, SARS-Cov2, originating in China, has been spreading around the world. As of 13 may 2020, almost 4.2 million cases of infections and 292 000 died were reported worldwide (...
Eligibility Criteria
Inclusion
- Very preterm children group :
- Children at elementary school age 7 to 9
- Children included in the cohort of EPIREMED study, born between 24 and 34 weeks' GA (gestational amenorrhea) and having visuospatial Working Memory impairment defined by a working memory index \<85 from the WPPSI IV
- Children able to read, write and comprehend;
- Children whose parents are not opposed to the participation in the study
- Children affiliated to the French social security system
- Control group :
- Children at elementary school age 7 to 9
- Children born at full-term and without dysexecutive disorders
- Children from the staff of the Assistance Publique - Hôpitaux de Marseille (AP-HM) / from the staff of the French Mediterranean network (PERINAT-MED) / from the close entourage of EPIREMED children
- Children able to read, write and comprehend
- Children whose parents are not opposed to the participation in the study
- Children affiliated to the French social security system
Exclusion
Key Trial Info
Start Date :
June 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT04696679
Start Date
June 19 2020
End Date
December 31 2020
Last Update
January 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique des Hopitaux de Marseille
Marseille, France